Low androgen level impairs erectile function of rat by regulating the Ng/CaN/AKT/eNOS pathway in penile corpus cavernosum
- PMID: 35678097
- DOI: 10.1111/andr.13202
Low androgen level impairs erectile function of rat by regulating the Ng/CaN/AKT/eNOS pathway in penile corpus cavernosum
Abstract
Background: The mechanism by which low androgen status inhibit erectile function has not yet been clearly elucidated. Neurogranin (Ng) is a Ca2+ -sensitive calmodulin binding protein that is expressed in endothelial cells and regulates eNOS function.
Objectives: To investigate whether low androgen status inhibit erectile function by regulating the Ng/CaN/AKT/eNOS pathway in the penile cavernous tissue of rats.
Materials and methods: Thirty-six 8-week-old male Sprague-Dawley rats were randomly divided into six groups as follows (n = 6): 4-week control group (4w-control), 4-week castration group (4w-cast), 4-week castration+testosterone replacement group (4w-cast+T), 8-week control group (8w-control), 8-week castration group (8w-cast), and 8-week castration+testosterone replacement group (8w-cast+T). Four weeks and eight weeks after surgery, the ratio of the maximum intracavernous pressure/mean arterial pressure (ICPmax/MAP) was examined. The level of NO and the expression of Ng, calcineurin (CaN), AKT, p-AKT(S473), eNOS, and p-eNOS(Ser1177) in the penile cavernous tissue of each group were determined.
Results: Ng and CaN were mainly expressed in the membrane and cytoplasm of endothelial cells and smooth muscle cells in the penile cavernous tissue of rats. The ICPmax/MAP and the concentration of NO in the cast group were significantly lower than those in the control group and cast+T replacement group (p < 0.01). The expression of Ng and the ratios of p-AKT/AKT and p-eNOS/eNOS in the penile cavernous tissue of rats in the cast group were significantly lower than those in the control group and cast+T replacement group (p < 0.01). The expression of CaN in the penile cavernous tissue of rats in the cast group was significantly increased compared with that in the control group and the cast+T replacement group (p < 0.01).
Conclusion: Inhibiting the expression of Ng and subsequently upregulating the expression of CaN in the rat penile cavernous tissue was one of the upstream mechanisms of low androgen status inhibiting erectile function by inhibiting the AKT/eNOS signaling pathway.
Keywords: androgen; calcineurin; eNOS; erectile dysfunction; neurogranin.
© 2022 American Society of Andrology and European Academy of Andrology.
Similar articles
-
Low androgen status inhibits erectile function by inducing eNOS uncoupling in rat corpus cavernosum.Andrology. 2020 Nov;8(6):1875-1883. doi: 10.1111/andr.12844. Epub 2020 Jul 12. Andrology. 2020. PMID: 32594586
-
[A low androgen state impairs erectile function by suppressing the expression of Tie2 in rat penile cavernosa].Zhonghua Nan Ke Xue. 2023 Aug;29(8):675-681. Zhonghua Nan Ke Xue. 2023. PMID: 38619512 Chinese.
-
Effect of low androgen status on the expression of adenosine A2A and A2B receptors in rat penile corpus cavernosum.Andrologia. 2019 Oct;51(9):e13344. doi: 10.1111/and.13344. Epub 2019 Jun 17. Andrologia. 2019. PMID: 31206753
-
The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function.J Sex Med. 2005 Nov;2(6):759-70. doi: 10.1111/j.1743-6109.2005.00094.x. J Sex Med. 2005. PMID: 16422801 Review.
-
Androgens and erectile dysfunction: from androgen deficiency to treatment.Sex Med Rev. 2024 Jun 26;12(3):458-468. doi: 10.1093/sxmrev/qeae030. Sex Med Rev. 2024. PMID: 38719619 Review.
Cited by
-
A low androgen state impairs erectile function by suppressing EPAC1 in rat penile corpus cavernosum.Transl Androl Urol. 2023 Oct 31;12(10):1528-1539. doi: 10.21037/tau-23-314. Epub 2023 Oct 22. Transl Androl Urol. 2023. PMID: 37969773 Free PMC article.
-
Hyperprolactinemia and male sexual function: focus on erectile dysfunction and sexual desire.Int J Impot Res. 2024 Jun;36(4):324-332. doi: 10.1038/s41443-023-00717-1. Epub 2023 Jun 20. Int J Impot Res. 2024. PMID: 37340146 Review.
References
REFERENCES
-
- Lue TF, Giuliano F, Montorsi F, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1(1):6-23.
-
- Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381(9861):153-165.
-
- Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50-56.
-
- Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016;2:16003.
-
- Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol. 2007;52(1):54-70.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous